Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2025)

Historic Current Leases for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q4 2025 value amounting to $3.3 million.

  • Enanta Pharmaceuticals' Current Leases rose 22673.96% to $3.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 million, marking a year-over-year increase of 22673.96%. This contributed to the annual value of $3.1 million for FY2025, which is 10643.04% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Current Leases of $3.3 million as of Q4 2025, which was up 22673.96% from $3.1 million recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Current Leases ranged from a high of $5.4 million in Q2 2023 and a low of $1.0 million during Q4 2024
  • Over the past 5 years, Enanta Pharmaceuticals' median Current Leases value was $3.4 million (recorded in 2021), while the average stood at $3.5 million.
  • Its Current Leases has fluctuated over the past 5 years, first plummeted by 7974.22% in 2024, then surged by 22673.96% in 2025.
  • Quarter analysis of 5 years shows Enanta Pharmaceuticals' Current Leases stood at $3.5 million in 2021, then increased by 0.49% to $3.5 million in 2022, then skyrocketed by 42.46% to $5.0 million in 2023, then tumbled by 79.74% to $1.0 million in 2024, then soared by 226.74% to $3.3 million in 2025.
  • Its Current Leases was $3.3 million in Q4 2025, compared to $3.1 million in Q3 2025 and $2.4 million in Q2 2025.